Bullish options flow was detected in DVAX stock on January 16, 2020.

Back on December 15, 2019, Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and Albertsons Companies, one of the largest food and drug retailers in the United States, have partnered to provide HEPLISAV-B at Albertsons Companies’ more than 1,700 pharmacies nationwide, with a special focus on people living with diabetes. Through this partnership, patients will have access to HEPLISAV-B, the only FDA-approved two-dose hepatitis B vaccine for adults that is completed in one month. HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older.

“Immunizations are an important part of preventative care and are crucial to preventing the spread of serious illness, like hepatitis B,” said Brian Hille, Vice President, Patient, Specialty and Wellness Services, Albertsons Companies. “Because diabetic patients are two times more likely to become infected with the hepatitis B virus and up to four times as likely to get HBV-related liver cancer, it makes sense to increase access to the HEPLISAV-B vaccine for these patients at our pharmacies, which are low barrier, easy access health and wellness centers in our communities.”

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV). It is estimated that 15 to 25 percent of patients with chronic hepatitis B develop chronic liver disease, including cirrhosis, liver failure, or liver cancer.i People living with diabetes are at increased risk for hepatitis B since the hepatitis B virus can be spread through everyday disease management activities such as sharing blood glucose meters, fingerstick devices or other diabetes-care equipment including syringes or insulin pens.ii The CDC recommends HBV vaccination for all adults with diabetes who are younger than 60 years old.iii

“We are committed to the prevention of hepatitis B by ensuring access to vaccines in all sites of care,” said Ryan Spencer, Co-President for Dynavax. “Community pharmacists play a major role in immunizing patients in their neighborhoods, and we are pleased that Albertsons Companies’ pharmacists will be able to help educate patients at risk for hepatitis B and conveniently provide vaccination with HEPLISAV-B.”

No appointment is necessary to receive the HEPLISAV-B vaccination at Albertsons Companies’ pharmacies during normal business hours. Hepatitis B vaccine and other vaccines, as permitted per state law, can be administered on a “walk-in” basis and are offered at more than 1,700 Albertsons Companies’ pharmacy locations, including those in Albertsons, Safeway, Vons, Jewel-Osco, Shaw’s, Acme, Tom Thumb, Randalls, Pavilions, Star Market, Haggen, and Carrs stores. Private insurers, Medicare and Medicaid are required to cover preventative HBV testing and vaccines usually without a deductible or co-pay. Payer coverage for HEPLISAV-B has been established for 100% of Medicare lives, more than 95% of Commercial lives, and 90% of Medicaid fee-for-service lives.

finviz dynamic chart for  dvax
Dynavax Technologies News From Google